SERVAL
serveur académique lausannois
Request copy of the document
The desired document is not currently available in SERVAL yet, but you can request a copy from the author(s) through the form below.
Your message will be sent directly to the UNIL/CHUV author(s) of the publication for which we have a valid email address and we leave it at their discretion to contact you and send your the copy manually. We cannot ensure that copy of the document will be sent to you.
In particular, the University draws your attention to the fact that the electronic copy can only be used for the strict purposes of illustration for teaching and academic and scientific research, as long as it is for a not-for-profit purpose, and that the source, including the author’s name, is indicated.
Your message will be sent directly to the UNIL/CHUV author(s) of the publication for which we have a valid email address and we leave it at their discretion to contact you and send your the copy manually. We cannot ensure that copy of the document will be sent to you.
In particular, the University draws your attention to the fact that the electronic copy can only be used for the strict purposes of illustration for teaching and academic and scientific research, as long as it is for a not-for-profit purpose, and that the source, including the author’s name, is indicated.
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial. | |
* : Mandatory fields
Last name *
First name *
E-mail *
Affiliation
Message
Captcha *
